AAV-mediated LRG1 overexpression in the adipose tissues led to a constellation of metabolic effects in both B6 and db/db mice, resulting in improvement of glucose/insulin tolerance as well as a reduction of obesity-associated inflammation. Here, LRG1 is linked to obesity disorder.